Evidence map›Paper›PMID 36014884›Full record

ArticleNutrients2022

Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer.

Julio José Jiménez-Alonso, Emilio Guillén-Mancina, José Manuel Calderón-Montaño, Víctor Jiménez-González, Patricia Díaz-Ortega, Estefanía Burgos-Morón, Miguel López-Lázaro

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Julio José Jiménez-AlonsoDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Sevilla, Spain.ORCID 0000-0002-2476-2507
Emilio Guillén-MancinaDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Sevilla, Spain.
José Manuel Calderón-MontañoDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Sevilla, Spain.ORCID 0000-0001-6845-797X
Víctor Jiménez-GonzálezDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Sevilla, Spain.
Patricia Díaz-OrtegaDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Sevilla, Spain.
Estefanía Burgos-MorónDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Sevilla, Spain.ORCID 0000-0002-6231-190X
Miguel López-LázaroDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, 41012 Sevilla, Spain.ORCID 0000-0003-2794-1647
Universidad de Sevilla · ES

Funding

AMINOVITA S.L. PRJ201803388
6 · The paper itself

Abstract

New therapies are needed to improve the low survival rates of patients with metastatic colon cancer. Evidence suggests that amino acid (AA) restriction can be used to target the altered metabolism of cancer cells. In this work, we evaluated the therapeutic potential of selective AA restriction in colon cancer. After observing anticancer activity in vitro, we prepared several artificial diets and evaluated their anticancer activity in two challenging animal models of metastatic colon cancer. These models were established by injecting CT26.WT murine colon cancer cells in the peritoneum (peritoneal dissemination) or in the tail vein (pulmonary metastases) of immunocompetent BALB/cAnNRj mice. Capecitabine, which is a first-line treatment for patients with metastatic colon cancer, was also evaluated in these models. Mice fed diet TC1 (a diet lacking 10 AAs) and diet TC5 (a diet with 6% casein, 5% glutamine, and 2.5% leucine) lived longer than untreated mice in both models; several mice survived the treatment. Diet TC5 was better than several cycles of capecitabine in both cancer models. Cysteine supplementation blocked the activity of diets TC1 and TC5, but cysteine restriction was not sufficient for activity. Our results indicated that artificial diets based on selective AA restriction have therapeutic potential for colon cancer.

Indexed as

Colonic NeoplasmsRectal NeoplasmsAmino AcidsAnimalsCapecitabineCysteineDietMiceAmino AcidsCapecitabineCysteineamino acidsanticancer activitycancer metabolismcolorectal cancercysteineglutamineleucinemetastasisselective amino acid restriction therapy

Identifiers

PMID36014884
PMCPMC9412877
OpenAlexW4292260851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.